Stem cell treatment for viral liver infections

Terapia com células-tronco: A Novel Approach for Viral Liver Infections

Viral liver infections pose a significant global health burden, leading to chronic liver disease, cirrose, and hepatocellular carcinoma. Apesar dos avanços nas terapias antivirais, there remains a need for novel therapeutic strategies to address the unmet medical needs of patients with viral liver infections. A terapia com células-tronco emergiu como uma abordagem promissora, offering the potential for liver regeneration, modulação imunológica, and viral clearance.

Pathogenesis of Viral Liver Infections and Stem Cell Potential

Viral liver infections, como o vírus da hepatite B (VHB) e vírus da hepatite C (HCV), cause liver damage through various mechanisms, including hepatocyte apoptosis, immune-mediated cytotoxicity, e fibrose. Células-tronco, including hepatic stem/progenitor cells (HSPC) e células-tronco mesenquimais (MSC), possess the ability to differentiate into hepatocytes and other liver cell types, contributing to liver regeneration and repair.

Stem Cells in Liver Regeneration and Repair

HSPCs and MSCs play crucial roles in liver regeneration and repair following injury or disease. HSPCs can differentiate into hepatocytes, colangiócitos, and oval cells, replenishing the damaged liver parenchyma. MSC, por outro lado, secrete paracrine factors that promote hepatocyte proliferation, reduzir a inflamação, e estimular a angiogênese.

Preclinical Studies of Stem Cell Therapy in Viral Liver Diseases

Preclinical studies in animal models of viral liver diseases have demonstrated the therapeutic potential of stem cell therapy. Transplantation of HSPCs or MSCs has been shown to improve liver function, reduzir a inflamação, and inhibit viral replication. These studies provide a strong rationale for further investigation of stem cell therapy in clinical settings.